Notes
glycosylated haemoglobin
2015 British pounds
Reference
Davies MJ, et al. Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting. PharmacoEconomics : 20 Jul 2016. Available from: URL: http://dx.doi.org/10.1007/s40273-016-0433-9
Rights and permissions
About this article
Cite this article
Once-daily IDegLira cost effective for T2DM in UK. PharmacoEcon Outcomes News 758, 24 (2016). https://doi.org/10.1007/s40274-016-3253-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3253-4